Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Urokinase Plasminogen Activator | 5 | 2019 | 15 | 0.750 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2018 | 78 | 0.390 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2014 | 30 | 0.300 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 37 | 0.280 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 22 | 0.200 |
Why?
|
| Podocytes | 2 | 2019 | 38 | 0.180 |
Why?
|
| Social Control, Formal | 1 | 2019 | 1 | 0.160 |
Why?
|
| Civil Rights | 1 | 2019 | 2 | 0.160 |
Why?
|
| Firearms | 1 | 2019 | 2 | 0.160 |
Why?
|
| Ownership | 1 | 2019 | 7 | 0.160 |
Why?
|
| Coronary Thrombosis | 1 | 2019 | 7 | 0.160 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 12 | 0.160 |
Why?
|
| Image Enhancement | 1 | 2018 | 45 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 35 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 66 | 0.150 |
Why?
|
| Contrast Media | 1 | 2018 | 68 | 0.150 |
Why?
|
| Atrial Appendage | 1 | 2018 | 29 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2018 | 9 | 0.150 |
Why?
|
| Thrombosis | 1 | 2018 | 48 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 98 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2018 | 60 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 105 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2014 | 39 | 0.140 |
Why?
|
| Apolipoproteins | 1 | 2017 | 7 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 24 | 0.140 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Proteinuria | 1 | 2017 | 47 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2019 | 159 | 0.140 |
Why?
|
| Hospitalization | 1 | 2019 | 292 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 126 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 177 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 129 | 0.120 |
Why?
|
| Male | 10 | 2021 | 13917 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cicatrix | 1 | 2014 | 7 | 0.110 |
Why?
|
| Risk Factors | 4 | 2021 | 2224 | 0.110 |
Why?
|
| Female | 9 | 2021 | 14273 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 28 | 0.100 |
Why?
|
| Middle Aged | 7 | 2019 | 8403 | 0.100 |
Why?
|
| Humans | 12 | 2021 | 25692 | 0.100 |
Why?
|
| Aged | 6 | 2019 | 8501 | 0.080 |
Why?
|
| Heart Failure | 1 | 2011 | 166 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2018 | 1633 | 0.080 |
Why?
|
| Apolipoprotein L1 | 2 | 2018 | 6 | 0.070 |
Why?
|
| Biomarkers | 2 | 2018 | 554 | 0.060 |
Why?
|
| Mice | 2 | 2019 | 1345 | 0.060 |
Why?
|
| United States | 2 | 2021 | 1943 | 0.060 |
Why?
|
| Adolescent | 2 | 2017 | 2076 | 0.050 |
Why?
|
| Transplantation, Autologous | 2 | 2012 | 151 | 0.050 |
Why?
|
| Animals | 2 | 2019 | 3510 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 427 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3220 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 15 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 7 | 0.040 |
Why?
|
| Adipocytes | 1 | 2019 | 20 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 17 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 49 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 61 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2019 | 33 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 62 | 0.040 |
Why?
|
| Echocardiography | 1 | 2019 | 88 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 199 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 217 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2019 | 96 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 23 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2018 | 67 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 20 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 4 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2019 | 410 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 443 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 190 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 646 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 326 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 584 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 7336 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 739 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 351 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 618 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 664 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 698 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 3231 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1336 | 0.030 |
Why?
|
| Muscle Development | 1 | 2014 | 5 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1084 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 43 | 0.030 |
Why?
|
| Tomography, Spiral Computed | 1 | 2014 | 25 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2014 | 49 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1277 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 3 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2012 | 16 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1689 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1781 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 248 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 1855 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 8 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 19 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4459 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 396 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 600 | 0.020 |
Why?
|